George Howard Selected Research

Thrombosis (Thrombus)

10/2015	Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial.
6/2011	Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin.
9/2006	Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

George Howard Research Topics

Disease

116	Stroke (Strokes) 02/2022 - 07/2001
40	Hypertension (High Blood Pressure) 01/2022 - 01/2002
27	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 05/2010
24	Carotid Stenosis (Carotid Artery Stenosis) 02/2022 - 06/2006
24	Ischemic Stroke 02/2022 - 05/2006
19	Coronary Disease (Coronary Heart Disease) 11/2021 - 08/2008
14	Myocardial Infarction 09/2021 - 07/2010
13	Atrial Fibrillation 09/2021 - 06/2006
12	Inflammation (Inflammations) 01/2022 - 06/2006
9	Cognitive Dysfunction 06/2021 - 05/2008
7	Pathologic Constriction (Stenosis) 12/2019 - 07/2001
7	Dyslipidemias (Dyslipidemia) 01/2019 - 06/2006
6	Chronic Renal Insufficiency 12/2021 - 08/2011
6	Sepsis (Septicemia) 12/2016 - 01/2013
5	Heart Failure 02/2022 - 07/2002
5	Infections 01/2021 - 06/2006
5	Heart Diseases (Heart Disease) 01/2019 - 02/2011
5	Diabetes Mellitus 03/2017 - 06/2014
5	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2015 - 10/2010
4	Obesity 01/2019 - 06/2006
4	Hemorrhage 01/2018 - 02/2007
4	Vascular Diseases (Vascular Disease) 01/2014 - 08/2008
3	Kidney Diseases (Kidney Disease) 02/2022 - 10/2010
3	Chronic Disease (Chronic Diseases) 01/2022 - 01/2021
3	Insulin Resistance 01/2021 - 06/2004
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2013
3	Isolated Systolic Hypertension 01/2020 - 03/2014
3	Neoplasms (Cancer) 01/2019 - 01/2008
3	Thrombosis (Thrombus) 10/2015 - 09/2006
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2014 - 06/2006
3	Albuminuria 03/2013 - 10/2010
3	Rheumatoid Arthritis 09/2012 - 09/2006
2	Atherosclerosis 01/2018 - 06/2011
2	Lung Diseases (Lung Disease) 01/2016 - 01/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2015 - 04/2007
2	Overweight 04/2011 - 04/2007
2	Migraine Disorders (Migraine) 06/2006 - 06/2006
2	Thrombophilia 06/2006 - 06/2006
2	Substance-Related Disorders (Drug Abuse) 06/2006 - 06/2006
2	Hyperhomocysteinemia 06/2006 - 06/2006
2	Sickle Cell Anemia (Hemoglobin S Disease) 06/2006 - 06/2006

Drug/Important Bio-Agent (IBA)

25	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 06/2004
19	C-Reactive ProteinIBA 01/2022 - 04/2007
18	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 07/2008
16	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 06/2006
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2006
10	LipidsIBA 01/2022 - 09/2009
9	LDL CholesterolIBA 01/2019 - 01/2002
8	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 04/2010
8	CreatinineIBA 01/2016 - 08/2008
8	AlbuminsIBA 01/2016 - 04/2009
7	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2018 - 05/2006
7	oxidized low density lipoproteinIBA 10/2018 - 08/2014
6	CholesterolIBA 11/2021 - 01/2014
6	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 01/2018
5	HDL CholesterolIBA 01/2019 - 01/2014
4	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 06/2004
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 01/2018
3	Factor VIII (Coagulation Factor VIII)IBA 01/2021 - 11/2015
3	Clopidogrel (Plavix)FDA Link 01/2020 - 02/2007
3	Hemoglobins (Hemoglobin)IBA 01/2020 - 05/2008
3	Triglycerides (Triacylglycerol)IBA 01/2019 - 01/2002
3	SmokeIBA 11/2015 - 06/2006
2	NeuropeptidesIBA 02/2022 - 01/2022
2	neuromedin NIBA 01/2022 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
2	NeurotensinIBA 01/2022 - 12/2020
2	antineoplaston A10 (A 10)IBA 12/2021 - 12/2015
2	Uric Acid (Urate)IBA 11/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 06/2021 - 01/2018
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 09/2012
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 02/2011
2	Insulin (Novolin)FDA Link 01/2021 - 06/2004
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2013
2	Cystatin CIBA 01/2021 - 01/2016
2	DiureticsIBA 11/2020 - 07/2009
2	Angiotensin Receptor AntagonistsIBA 01/2020 - 10/2010
2	Biological ProductsIBA 10/2019 - 07/2011
2	insulin receptor-related receptor (IRR)IBA 01/2019 - 06/2011
2	Natriuretic PeptidesIBA 01/2019 - 01/2018
2	SodiumIBA 10/2018 - 09/2014
2	PotassiumIBA 10/2018 - 09/2014
2	Polyvinyl Chloride (PVC)IBA 01/2017 - 05/2015
2	fibrin fragment D (D-dimer)IBA 01/2017 - 11/2015
2	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 08/2016 - 11/2014
2	Tobacco Smoke Pollution (Passive Smoking)IBA 12/2015 - 09/2011
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2010 - 07/2002
2	Digoxin (Digitek)FDA LinkGeneric 12/2009 - 07/2009
2	Lipoprotein(a)IBA 06/2006 - 06/2006
2	Hormones (Hormone)IBA 06/2006 - 06/2006
2	Phospholipases (Phospholipase)IBA 06/2006 - 06/2006

Therapy/Procedure

31	Carotid Endarterectomy 01/2022 - 07/2001
27	Endarterectomy (Thromboendarterectomy) 01/2022 - 07/2001
18	Therapeutics 01/2022 - 05/2006
8	Stents 01/2021 - 12/2004
6	Secondary Prevention 09/2021 - 10/2004
3	Treatment Delay 08/2016 - 11/2014
2	Aftercare (After-Treatment) 01/2019 - 11/2014
2	Time-to-Treatment 08/2016 - 01/2016
2	Mediterranean Diet 03/2015 - 04/2013